| Financial Year |
March 31 2023 |
| Monetary Funds |
1,586,065,788.26 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
15,361,183.11 |
| Accounts Receivable |
607,419,551.58 |
| Advances to Suppliers |
174,008,904.17 |
| Other Receivables |
128,639,158.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
144,342,104.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
99,705,035.95 |
| Total Current Assets |
3,087,781,192.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
781,016,251.70 |
| Investment Properties |
-- |
| Fixed Assetes |
1,895,909,249.87 |
| Under-construction Projects |
525,818,142.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,404,523,335.64 |
| R&D expenses |
5,725,145.65 |
| Goodwill |
1,144,183,225.92 |
| Long-Term Deferred and Prepaid Expenses |
52,154,303.14 |
| Deferred Income Tax Assets |
167,548,003.26 |
| Other Non-Current Assets |
144,000,631.18 |
| Sub-Total of Non-Current Assets |
6,182,606,827.93 |
| Total Assets |
9,270,388,020.71 |
| Short-Term Loans |
647,236,908.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,401,884,500.00 |
| Accounts Payable |
598,805,927.47 |
| Accounts Received In Advance |
254,283.94 |
| Employee Compensation Payable |
12,898,730.54 |
| Taxes Payable |
124,047,909.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
457,215,463.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
230,474,804.41 |
| Other Current Liabilities |
26,335,700.25 |
| Sub-Total of Current Liabilities |
3,629,496,353.60 |
| Long-term Loans |
105,575,145.87 |
| Bonds Payable |
368,263,659.51 |
| Long-Term Accounts Payable |
304,788,565.32 |
| Special Payable |
-- |
| Estimatied Liabilities |
149,038,223.61 |
| Deferred Income Tax Liabilities |
299,805,076.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,259,608,966.72 |
| Total Liabilities |
4,889,105,320.32 |
| Paid-In Capital(Or Share Stock) |
881,899,053.00 |
| Capital Surplus |
1,881,068,766.19 |
| Surplus Reserve |
56,559,764.94 |
| LESS:Treasury Stock |
85,559,136.82 |
| Undistributed Profits |
1,375,994,717.30 |
| Minority Stockholder's Interest |
162,158,085.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,219,124,615.18 |
| Owner's Equity（Stockholder's Equity） |
4,381,282,700.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,270,388,020.71 |
